7,735.25

+14.75

+0.19%

53,836.00

+333.00

+0.62%

28,450.00

-116.75

-0.41%

Russell 2000 Futures

2,882.50

+16.60

+0.58%

4.8940

-0.0580

-1.17%

16.79

+0.18

+1.08%

4,142.90

+69.90

+1.72%

80,130.21

+1,940.51

+2.48%

Crude Oil Dec 26

89.45

+1.33

+1.51%

US Private Equity

10,904.74

+49.51

+0.46%

OTC Markets OTCQB - Delayed Quote USD

Radnostix, Inc. (INIS)

0.0500 0.0000 (0.00%)

At close: November 4 at 4:00:00 PM EST

Loading Chart for INIS

Chart Range Bar

Interval:

In partnership with ChartIQ

Radnostix and NANO Nuclear Energy Announce Joint Submission of Letter of Intent to NRC Seeking Consent for Transfer of License SUB-1011, Following Lea County Approval of Property LOI

Radnostix and NANO Nuclear Energy Announce Joint Submission of Letter of Intent to NRC Seeking Consent for Transfer of License SUB-1011, Following Lea County Approval of Property LOI

Radnostix Signs Definitive Agreement to Divest DUF6 and Fluorine Assets to NANO Nuclear

Radnostix Signs Definitive Agreement to Divest DUF6 and Fluorine Assets to NANO Nuclear

Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025

Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025

NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets

NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets

Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio

Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio

Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown

Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown

Mutual Termination of the Asset Purchase Agreement related to the Radnostix DUF6 Assets

Mutual Termination of the Asset Purchase Agreement related to the Radnostix DUF6 Assets

International Isotopes Inc. Announces Company Name Change to Radnostix, Inc.

International Isotopes Inc. Announces Company Name Change to Radnostix, Inc.

Mobilize your Website

View Site in Mobile | Classic

Share by: